semaglutide fda shortage status january 2025 crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many How Ozempic Maker Novo Nordisk

We thank Shigetoshi Koga (Kurume University) for laboratory animal care

All that WADA has to do is (a) reclassify the Section 4 Substances as Threshold Substances (or otherwise treat them the same), and (b) allow the concentration of the relevant substance in the B sample to be calculated and taken into account to determine whether an anti-doping rule violation should be pursued

The options it mentions, such as escalation or medication cycling, are explicitly framed as things to be considered with provider guidance rather than adjusted independently

This approach allowed us to explore broad themes such as the effects of GLP-1 RAs on osteoblast and osteoclast activity, bone formation and resorption, and the overall impact on bone integrity and healing